Evaluation of salivary IL-10 and IL-8 as predictive biomarker in patient with oral and oropharyngeal squamous cell carcinoma
Authors:
Open Access
- 21 February 2024
- journal article
- research article
- Published by Journal of Ideas in Health in Journal of Ideas in Health
- Vol. 7 (1) , 1001-1006
Abstract
Background: The incidence and mortality rates of oral squamous cell carcinoma (OSCC) vary globally, yet the cancer continues to pose significant morbidity and mortality risks. This study sought to assess salivary IL-8 and IL-10 as biomarkers for identifying malignant oral lesions. Methods: Between March 2022 and May 2023, a case-control study at the Dental Center of New Baquba, Diyala, Iraq, collected saliva for IL-8 and IL-10 measurement via ELISA. An independent t-test compared IL-8 and IL-10 means based on age and gender, while ROC analysis gauged specificity and sensitivity. Results: The prevalence of OSCC was evenly distributed across genders, with a higher occurrence among patients aged over 55 years (87.5%). OSCC distribution in the oral cavity indicated the lips as the most affected area (40.0%), followed by the tongue (37.0%), and the hard and soft palate (12.50%). Statistically significant differences were noted in IL-10 and IL-8 levels between the study and control groups across all age brackets, except for IL-8 in the age ≤55 (p ≤ 0.05). Elevated mean levels of IL-10 and IL-8 were observed in the older age group (>55), with IL-10 showing a greater increase in males (71.99±3.6), while IL-8 levels were higher in females. IL-10 demonstrated higher sensitivity (90%) and specificity (60%) with an optimal cutoff point value of 43.29, whereas IL-8 exhibited a sensitivity of 80% and a specificity of 47.5% with an optimal cutoff point value of 44.48. Conclusion: Individuals aged over 55 showed higher IL-10 and IL-8 levels, particularly in males for IL-10 and in females for IL-8. Salivary biomarkers hold promise for early OSCC detection.Keywords
This publication has 36 references indexed in Scilit:
- IL‐8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR‐146a mediated mechanismMolecular Carcinogenesis, 2023
- Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt/Erk-NFκB axis in oral cancerCytokine, 2023
- Role of IL-6 and IL-8 biomarkers for optical and electrochemical based point-of-care detection of oral cancerBiosensors and Bioelectronics: X, 2022
- Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6International Dental Journal, 2022
- Role of Salivary Biomarkers in Oral Cancer Detection2018
- High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patientsClinica Chimica Acta, 2013
- The Use of Biomarkers for Detection of Early- and Late-Onset Neonatal Sepsis2012
- Serum IL10 and circulating CD4+CD25high regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinomaHead & Neck, 2011
- NF-κB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinomaCancer Detection Prevention, 2005
- Interleukin-8 Expression by Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1995